Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.
42 results about "Drug resistant tuberculosis" patented technology
Filter
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Extensively drug-resistant tuberculosis (XDR-TB) is a newly described category of TB that is resistant to fluoroquinolone (a strong antibiotic like ciprofloxacin) and capreomycin, kanamycin, or amikacin, drugs currently used for MDR-TB. XDR-TB is extremely difficult to treat.